Intellectual Property India Publishes Patent Application for Novel Crystalline Forms Of 4-[3chloro-4-(n’-Cyclopropylureido)phenoxy]-7-Methoxyquino Line-6-Carboxamide Ethanesulfonate And Process For The Preparation Thereof

MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202441098160 A) filed by Msn Laboratories Private Limited, R&d Center on December 12, 2024, for Novel Crystalline Forms Of 4-[3chloro-4-(n’-Cyclopropylureido)phenoxy]-7-Methoxyquino Line-6-Carboxamide Ethanesulfonate And Process For The Preparation Thereof.

Inventors include Srinivasan Thirumalai Rajan; Sagyam Rajeshwar Reddy; Kammari Balraju; and Kamutam Sathish.

The application for the patent was published on June 19, 2026, under issue no. 25/2026.

Abstract: Title: Novel crystalline forms of 4-[3chloro-4-(N’-cyclopropylureido)phen oxy]-7-methoxyquinoline-6-carboxamide ethanesulfonate and process for the preparation thereof The present application relates to a novel crystalline forms of 4-[3chloro-4-(N’-cyclopropylureido)phenoxy]-7-methoxyquinoline-6-carboxamide ethanesulfonate which is represented by the following structural formula-1b, which is referred to as Lenvatinib ethanesulfonate.

Disclaimer: Curated by HT Syndication.